Nordea raises the target price of Devyser to 140 SEK (125) and reiterates its purchase offer.

Devyser Diagnostics AB is a Sweden-based company that develops, manufactures and sells kits for genetic testing in routine diagnostic laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology and post-transplant monitoring to diagnose genetic diseases and target cancer treatment. Since its inception, the company has developed and launched nearly 30 products for routine diagnostics, including the Devyser Thrombophilia test as well as Devyser Resolution XY for the analysis of X and Y chromosomes. Devyser Diagnostics’ products are sold directly to the customer final or through committed distributors. The company supplies its products to more than 45 countries.

More information about the company

-

-

PREV in Bègles, the television broadcast of the Lionesses match applauded by the supporters
NEXT Drunk and speeding on the expressway, the driver fled before being arrested in the city center in Quimper